Exact Mass: 239.0689
Exact Mass Matches: 239.0689
Found 500 metabolites which its exact mass value is equals to given mass value 239.0689,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Clomazone
CONFIDENCE standard compound; INTERNAL_ID 45; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8803; ORIGINAL_PRECURSOR_SCAN_NO 8801 CONFIDENCE standard compound; INTERNAL_ID 45; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8849; ORIGINAL_PRECURSOR_SCAN_NO 8847 CONFIDENCE standard compound; INTERNAL_ID 45; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8896; ORIGINAL_PRECURSOR_SCAN_NO 8895 CONFIDENCE standard compound; INTERNAL_ID 45; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8910; ORIGINAL_PRECURSOR_SCAN_NO 8909 CONFIDENCE standard compound; INTERNAL_ID 45; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8860; ORIGINAL_PRECURSOR_SCAN_NO 8859 CONFIDENCE standard compound; INTERNAL_ID 45; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8907; ORIGINAL_PRECURSOR_SCAN_NO 8906 CONFIDENCE standard compound; EAWAG_UCHEM_ID 139 CONFIDENCE standard compound; INTERNAL_ID 2548 CONFIDENCE standard compound; INTERNAL_ID 4056 CONFIDENCE standard compound; INTERNAL_ID 8432
Dihydrobiopterin
Dihydrobiopterin, also known as BH2, 7,8-dihydrobiopterin, L-erythro-7,8-dihydrobiopterin, quinonoid dihydrobiopterin or q-BH2, belongs to the class of organic compounds known as biopterins and derivatives. These are coenzymes containing a 2-amino-pteridine-4-one derivative. Dihydrobiopterin is also classified as a pteridine. Pteridines are aromatic compounds composed of fused pyrimidine and pyrazine rings. Dihydrobiopterin is produced during the synthesis of neurotransmitters L-DOPA, dopamine, norepinephrine and epinephrine. It is restored to the required cofactor tetrahydrobiopterin via the NADPH-dependant reduction of dihydrobiopterin reductase. Dihydrobiopterin can also be converted to tetrahydrobiopterin by nitric oxide synthase (NOS) which is catalyzed by the flavoprotein "diaphorase" activity of NOS. This activity is located on the reductase (C-terminal) domain of NOS, whereas the high affinity tetrahydrobiopterin site involved in NOS activation is located on the oxygenase (N-terminal) domain (PMID: 8626754). Sepiapterin reductase (SPR) is another enzyme that plays a role in the production of dihydrobiopterin. SPR catalyzes the reduction of sepiapterin to dihydrobiopterin (BH2), the precursor for tetrahydrobiopterin (BH4). BH4 is a cofactor critical for nitric oxide biosynthesis and alkylglycerol and aromatic amino acid metabolism (PMID: 25550200). Dihydrobiopterin is known to be synthesized in several parts of the body, including the pineal gland. Dihydrobiopterin exists in all eukaryotes, ranging from yeast to humans. In humans, dihydrobiopterin is involved in several metabolic disorders including dihydropteridine reductase (DHPR) deficiency. DHPR deficiency is a severe form of hyperphenylalaninemia (HPA) due to impaired regeneration of tetrahydrobiopterin (BH4) leading to decreased levels of neurotransmitters (dopamine, serotonin) and folate in cerebrospinal fluid, and causing neurological symptoms such as psychomotor delay, hypotonia, seizures, abnormal movements, hypersalivation, and swallowing difficulties. Dihydrobiopterin is also associated with another metabolic disorder known as sepiapterin reductase deficiency (SRD). Sepiapterin reductase catalyzes the (NADP-dependent) reduction of carbonyl derivatives, including pteridines, and plays an important role in tetrahydrobiopterin biosynthesis. Low dihydrofolate reductase activity in the brain leads to the accumulation of dihydrobiopterin, which in turn, inhibits tyrosine and tryptophan hydroxylases. This uncouples neuronal nitric oxide synthase, leading to neurotransmitter deficiencies and neuronal cell death. SRD is characterized by low cerebrospinal fluid neurotransmitter levels and the presence of elevated cerebrospinal fluid dihydrobiopterin. SRD is characterized by motor delay, axial hypotonia, language delay, diurnal fluctuation of symptoms, dystonia, weakness, oculogyric crises, dysarthria, parkinsonian signs and hyperreflexia. Dihydrobiopterin (BH2) is an oxidation product of tetrahydrobiopterin. Tetrahydrobiopterin is a natural occurring cofactor of the aromatic amino acid hydroxylase and is involved in the synthesis of tyrosine and the neurotransmitters dopamine and serotonin. Tetrahydrobiopterin is also essential for nitric oxide synthase catalyzed oxidation of L-arginine to L-citrulline and nitric oxide. [HMDB] 7,8-Dihydro-L-biopterin is an oxidation product of tetrahydrobiopterin.
4a-Carbinolamine tetrahydrobiopterin
Carbinolamine 4a-hydroxytetrahydrobiopterin is formed as a consequence of the hydroxylation of phenylalanine to tyrosine. During the physiological reaction tetrahydrobiopterin (the naturally occurring cofactor for phenylalanine hydroxylase), and the two substrates phenylalanine and molecular oxygen combine with phenylalanine hydroxylase to form a quarternary complex. An enzyme, 4a-carbinolamine dehydratase, catalyzes the reaction. (PMID: 2722790) [HMDB] Carbinolamine 4a-hydroxytetrahydrobiopterin is formed as a consequence of the hydroxylation of phenylalanine to tyrosine. During the physiological reaction tetrahydrobiopterin (the naturally occurring cofactor for phenylalanine hydroxylase), and the two substrates phenylalanine and molecular oxygen combine with phenylalanine hydroxylase to form a quarternary complex. An enzyme, 4a-carbinolamine dehydratase, catalyzes the reaction. (PMID: 2722790). COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
6-Lactoyltetrahydropterin
6-Lactoyltetrahydropterin is a putative intermediate in the de novo synthesis of tetrahydrobiopterin (BH4) pathway, in a reaction involving the enzyme sepiapterin reductase (E.C. 1.1.1.153) in human liver. In brain, an enzyme distinct from sepiapterin reductase catalyzes the TPNH-dependent reduction of 6-pyruvoyl-tetrahydropterin to 6-lactoyl-tetrahydropterin. (PMID: 4004850). In brain, the expression of other enzymes involved in BH4 biosynthesis includes aldose reductase, carbonyl reductase, GTP-cyclohydrolase I, and 6-pyruvoyltetrahydrobiopterin. Sepiapterin reductase expression is increased in Parkinsons disease brain tissue. (PMID: 17270157). 6-Lactoyltetrahydropterin is a putative intermediate in the de novo synthesis of tetrahydrobiopterin (BH4) pathway, in a reaction involving the enzyme sepiapterin reductase (E.C. 1.1.1.153) in human liver. In brain, an enzyme distinct from sepiapterin reductase catalyzes the TPNH-dependent reduction of 6-pyruvoyl-tetrahydropterin to 6-lactoyl-tetrahydropterin. (PMID: 4004850)
1-hydroxy-2-Oxopropyl tetrahydropterin
1-hydroxy-2-Oxopropyl tetrahydropterin, an intermediate formed from 6-Pyrovoyl-Tetrahydropterin in the biosynthetic pathway of tetrahydrobiopterin [PMID: 19234759]. [HMDB] 1-hydroxy-2-Oxopropyl tetrahydropterin, an intermediate formed from 6-Pyrovoyl-Tetrahydropterin in the biosynthetic pathway of tetrahydrobiopterin [PMID: 19234759].
Marcanine A
Marcanine A is found in alcoholic beverages. Marcanine A is an alkaloid from Annona glabra (pond apple). Alkaloid from Annona glabra (pond apple). Marcanine A is found in alcoholic beverages and fruits.
O2'-4a-cyclic-tetrahydrobiopterin
O2-4a-cyclic-tetrahydrobiopterin is a novel pterin intermediate, in addition to the expected 4a-hydroxytetrahydrobiopterin (4a-OH-BH4) and quinonoid dihydrobiopterin generated during catalytic turnover of tyrosine hydroxylase (TH) with tetrahydrobiopterin as the cofactor. Its conversion into quinonoid dihydrobiopterin is catalysed by pterin-4a-carbinolamine dehydratase.
N-Gluconyl ethanolamine
N-Gluconyl ethanolamine is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") It is used as a food additive .
N-Ornithyl-L-taurine
Proposed salt substitute especially for soy sauce. The originally-claimed saltiness at this compound was disputed, but has subsequently been confirmed. Proposed salt substitute especies for soy sauce. The originally-claimed saltiness at this compound was disputed, but has subsequently been confirmed.
S-Phenylmercapturic acid
S-phenylmercapturic acid belongs to the family of N-acyl-alpha Amino Acids and Derivatives. These are compounds containing an alpha amino acid which bears an acyl group at his terminal nitrogen atom.
9-Carboxymethoxymethylguanine
9-Carboxymethoxymethylguanine is a metabolite of aciclovir. Aciclovir or acyclovir, chemical name acycloguanosine, abbreviated as ACV, is a guanosine analogue antiviral drug, marketed under trade names such as Cyclovir, Herpex, Acivir, Acivirax, Zovirax, and Xovir. One of the most commonly used antiviral drugs, it is primarily used for the treatment of herpes simplex virus infections, as well as in the treatment of varicella zoster (chickenpox) and herpes zoster (shingles). (Wikipedia)
2'-Deoxy-2'-methylenecytidine
D-Erythro-7,8-dihydrobiopterin
Cyclopentenyl cytosine
Flosequinan
C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases > C01DB - Quinolone vasodilators C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
3-benzylidene-4-(1(3)H-imidazol-4-yl)-pyrrolidin-2-one|Noranantin
2-acetamido-2-[3-hydroxy-4-(hydroxymethyl)phenyl]acetic acid
Xanthiazone
Xanthiazone is a natural product found in Xanthium strumarium with data available.
4-oxo-1,4-dihydrobenzo[h]quinoline-3-carboxylic acid
2-(3-Methyl-5-oxo-2,5-dihydro-furan-2-ylmethyl)-quinoline
C11H13NO5_1H-Pyrrole-3-propanoic acid, 5-acetyl-4-(carboxymethyl)
dihydrobiopterin
7,8-Dihydro-L-biopterin is an oxidation product of tetrahydrobiopterin.
Mebendazole metabolite (1H-Benzimidazole-5-methanol, 2-amino-a-phenyl-)
7,8-Dihydro-L-biopterin
7,8-Dihydro-L-biopterin is an oxidation product of tetrahydrobiopterin.
Acyclovir (8-hydroxy-9-(2-hydroxythoxymethyl)guanine
Ketamine metabolite (Cyclohexanone, 2-amino-2-(2-chlorophenyl)-6-hydroxy-)
Ketamine metabolite (Cyclohexanone, 2-amino-2-(2-chlorophenyl)-5-hydroxy-)
(2S,4S)-2-(4-methylphenyl)-4-propan-2-yl-1-oxa-2λ6-thia-3-azacyclopent-2-ene 2-oxide
2-Chloro-6-[(cyclopropylcarbonyl)amino]benzoic acid
spiro[1H-pyrrolo[2,3-b]pyridine-3,4-piperidine]-2-one,hydrochloride
(2S,4S)-4-(3-chlorobenzyl)pyrrolidine-2-carboxylic acid
5-(5-METHYLTHIEN-3-YL)-4-PROPYL-4H-1,2,4-TRIAZOLE-3-THIOL
4-ethyl-3-(5-ethylthiophen-3-yl)-1H-1,2,4-triazole-5-thione
4-METHYL-5-(5-PROPYLTHIEN-3-YL)-4H-1,2,4-TRIAZOLE-3-THIOL
5-(5-ISOPROPYLTHIEN-3-YL)-4-METHYL-4H-1,2,4-TRIAZOLE-3-THIOL
3-(4,5-dimethylthiophen-3-yl)-4-ethyl-1H-1,2,4-triazole-5-thione
5-(4-ETHYL-5-METHYLTHIEN-3-YL)-4-METHYL-4H-1,2,4-TRIAZOLE-3-THIOL
4-Methylamino-6-morpholin-4-yl-[1,3,5]triazine-2-carboxylic acid
1-(2-thienylcarbonyl)piperidine-4-carboxylic acid(SALTDATA: FREE)
(S)-2-(3-chloro-2-hydroxypropyl)isoindoline-1,3-dione
2H-SPIRO[BENZOFURAN-3,4-PIPERIDIN]-2-ONE HYDROCHLORIDE
3-CYANO-5-HYDROXY-[1,1-BIPHENYL]-3-CARBOXYLIC ACID
2-Butenenitrile, 2-hydroxy-3-(6-methoxy-2-naphthalenyl)-
Ethyl 2-amino-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
N-[3,5-Difluoro-4-(trifluoromethyl)phenyl]acetamide
2-Oxazolidinone,5-methyl-3-[[(5-nitro-2-furanyl)methylene]amino]-
2-(AMINOMETHYL)-N1,N1-DIMETHYLPROPANE-1,3-DIAMINE TRIHYDROCHLORIDE
6,7-difluoro-8-methyl-4-oxo-1H-quinoline-3-carboxylic acid
ethyl 2-amino-5,6,7,8-tetrahydro-4h-cyclohepta[b]thiophene-3-carboxylate
3-(Trifluoromethyl)-6,7,8,9-tetrahydro-5H-carbazole
5-amino-1-(2,4-difluorophenyl)pyrazole-4-carboxylic acid
Methyl 6,8-difluoro-4-oxo-1,4-dihydroquinoline-2-carboxylate
2-AMINO-3-TRIFLUOROMETHYLACETOPHENONE HYDROCHLORIDE
4-Isoxazolecarboxylic acid,4-(4-chlorophenyl)-4,5-dihydro-3-methyl-,(+)-
(E)-N-(2-Chloro-6-methylphenyl)-3-ethoxyacrylamide
2-(4-METHOXY-PHENYL)-THIAZOLIDINE-4-CARBOXYLIC ACID
1-(3-TRIFLUOROMETHYL-PHENYL)-1H-PYRROLE-2-CARBALDEHYDE
3H-SPIRO[ISOBENZOFURAN-1,4-PIPERIDIN]-3-ONE HYDROCHLORIDE
Methyl 6,8-difluoro-4-hydroxy-2-quinolinecarboxylate
3-AMINO-3-(4-METHOXY-BENZO[1,3]DIOXOL-6-YL)-PROPIONIC ACID
1-[(2,6-Difluorophenyl)methyl]-1H-1,2,3-triazole-4-carboxylic acid
1H-Benzimidazole-7-carboxylic acid, 2-(3-pyridinyl)-
N1-METHYL-3-(METHYLTHIO)-6,7-DIHYROBENZO[C]THIOPHENE-1-CARBOXAMIDE
propyl 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
2-PYRIDIN-4-YL-3H-BENZOIMIDAZOLE-4-CARBOXYLIC ACID
1-(2-chlorophenyl)-5-oxopyrrolidine-3-carboxylic acid
1-(3-CHLORO-PHENYL)-3,3-BIS-METHYLSULFANYL-PROPENONE
4-Chloro-2-[(cyclopropylcarbonyl)amino]benzoic acid
1-(3-CHLORO-PHENYLAMINO)-CYCLOPENTANECARBOXYLIC ACID
1H-Benzimidazole-7-carboxylic acid, 2-(2-pyridinyl)-
(3-CHLORO-4-(CYCLOPROPYLCARBAMOYL)PHENYL)BORONIC ACID
Methyl 4-(Trifluoromethyl)benzimidate Hydrochloride
2-AMINO-4,5,6,7,8,9-HEXAHYDROCYCLOOCTA[B]-THIOPHENE-3-CARBOXYLICACIDMETHYLESTER
1-(4-chloro-phenyl)-5-oxo-pyrrolidine-3-carboxylic acid
6-CHLORO-3-HYDROXY-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER
2-pyridin-4-yl-3h-benzoimidazole-5-carboxylic acid
(2R,4R)-(+)-4-ISOPROPYL-2-P-TOLUENE-4,5-DIHYDRO-(1,2LAMBDA6,3)-OXATHIAZOLE 2-OXIDE
2-amino-1-[4-(trifluoromethyl)phenyl]ethanone,hydrochloride
diethyl (n-methoxy-n-methylcarbamoylmethyl)phosphonate
Meseclazone
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
1H-Benzimidazole-4-carboxamide,2-(methylsulfonyl)-
2-FLUORO-5-((TETRAHYDRO-2H-PYRAN-4-YL)AMINO)BENZOIC ACID
BENZENEACETIC ACID, 4-METHOXY-2-NITRO-, ETHYL ESTER
(3-CHLOROQUINOXALIN-2-YL)(PHENYLSULFONYL)ACETONITRILE
Diethyl 4-oxo-1,4-dihydro-3,5-pyridinedicarboxylate
1-[4-(trifluoromethyl)phenyl]-1H-pyrrole-2-carbaldehyde
ETHYL 3-(4-AMINO-2-(METHYLTHIO)PYRIMIDIN-5-YL)ACRYLATE
5-[(2-methylpropan-2-yl)oxycarbonylamino]pyrazine-2-carboxylic acid
SULFURIC ACID COMPOUND WITH 3-METHYLPIPERIDINE-1-CARBOXIMIDAMIDE (1:1)
methyl 4-(3-chlorophenyl)pyrrolidine-3-carboxylate
methyl 4-(2-chlorophenyl)pyrrolidine-3-carboxylate
3-Amino-N-(3,4-dihydro-2H-pyrrol-5-yl)benzenesulfonamide
ETHYL 4-CHLORO-1-METHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE
[4-[(carbamothioylamino)carbamoyl]phenyl]boronic acid
(2S,4R)-4-(2-Chlorobenzyl)pyrrolidine-2-carboxylic acid
Ethyl 6-chloro-2-methylimidazo[1,2-b]pyridazine-3-carboxylate
(4-Chloro-3-(cyclopropylcarbamoyl)phenyl)boronic acid
Ethyl 4-chloro-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxylate
2,2-DIPHENYLETHYL ISOTHIOCYANATE
SF5 (2,2-Diphenylethyl isothiocyanate) is a sulforaphane analog. SF5 inhibits apoptosis by the JNK-p53-caspase pathway. SF5 can be used as a new renal protective agent for drug-resistant acute renal disease[1].
ETHYL 3-AMINO-6-CHLORO-5-CYANO-2-METHYLISONICOTINATE
tert-Butyl 6,7-dihydrothieno[3,2-c]pyridine-5(4H)-carboxylate
1-(4-Fluorophenyl)-1,3-dihydro isobenzofuran-5-carbonitile
2-ChloroMethyl-3-Methyl-4-(2,2,2-trifluoroethoxy)pyridine
methyl 3-(trifluoromethyl)benzimidate hydrochloride
2-chloro-4-(cyclopentylamino)-5-pyrimidinyl ethanone
3-(Trifluoromethyl)benzenepropanamine hydrochloride
Hydrazinecarbodithioic acid, [1-(2-pyridinyl)propylidene]-, methyl ester
(2S,4R)-4-(4-chlorobenzyl)pyrrolidine-2-carboxylic acid
(2Z)-6-Hydroxy-2-(pyridin-2-ylmethylene)-1-benzofuran-3(2H)-one
2-acetamido-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid
4-(5-Oxo-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide
Aziridine,2-(1-Methylethyl)-1-[(4-Methylphenyl)sulfonyl]-, (2S)-
(R)-1-(5-CHLORO-2-METHOXY-PHENYL)-2,2,2-TRIFLUORO-ETHYLAMINE
Trans-Methyl 4-(4-chlorophenyl)pyrrolidine-3-carboxylate-HCl
1,3-Benzenedicarboxylicacid, 5-nitro-, 1-ethyl ester
3-PYRROLIDINECARBOXYLIC ACID, 1-(4-CHLOROPHENYL)-2-OXO-
(S)-2-(tert-Butoxycarbonylamino)-4,4-difluorobutanoic acid
N-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]ethane-1,2-diamine
ETHYL 2-AMINO-7-OXO-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXYLATE
Methyl 5-(2,4-Difluorophenyl)isoxazole-3-carboxylate
5-Chloro-2-[(cyclopropylcarbonyl)amino]benzoic acid
9-Carboxymethoxymethylguanine
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents
9-(3,4-Dihydroxybutyl)guanine
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents
2-Amino-3-phenylmethoxybutanedioic acid
D018377 - Neurotransmitter Agents > D018846 - Excitatory Amino Acids
DMDC
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors
Benzoic acid, 2-[(carboxymethyl)methylamino]-5-methoxy-
3-[(1-Amino-2-carboxy-ethyl)-hydroxy-phosphinoyl]-2-methyl-propionic acid
flosequinan
C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases > C01DB - Quinolone vasodilators C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
N-Acetyl-S-phenyl-L-cysteine
The S-phenyl derivative of N-acetyl-L-cysteine. It is a urinary metabolite of benzene and used as a biomarker to assess benzene exposure.
3-Carboxy-4-methyl-5-propyl-2-furanpropanoate
A dicarboxylic acid monoanion that is the conjugate base of 2-(2-carboxyethyl)-4-methyl-5-propylfuran-3-carboxylic acid.
3-[5-acetyl-4-(carboxymethyl)-1H-pyrrol-3-yl]propanoic acid
(6R)-6-lactoyl-5,6,7,8-tetrahydropterin
A 6-lactoyl-5,6,7,8-tetrahydropterin in which the stereocentre at position 6 has R-configuration.
6-Hydroxyphenazine-1-carboxylate
A hydroxy monocarboxylic acid anion that is the conjugate base of 6-hydroxyphenazine-1-carboxylic acid resulting from the deprotonation of the carboxy group; major microspecies at pH 7.3.
(6R)-6-(L-erythro-1,2-Dihydroxypropyl)-7,8-dihydro-6H-pterin
2-amino-6-(2-hydroxypropanoyl)-4a,7,8,8a-tetrahydro-3H-pteridin-4-one
(2S)-2-amino-N-[(Z)-(4-methyl-2,6-dioxo-5-pyrimidinylidene)methyl]propanehydrazide;hydrochloride
2-amino-6-[(1R)-1,2-dihydroxypropyl]-7,8-dihydro-1H-pteridin-4-one
2-[(6-Hydroxy-1,3-benzodioxole-5-carbonyl)amino]acetic acid
3a,4-Dihydro-2-(4-methylphenyl)-2H-isoindole-1,3-dione
6,7-Dihydrobiopterin
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(6R)-D-erythro-6,7-dihydrobiopterin
A 6,7-dihydrobiopterin that has R configuration at position 6 and in which the 1,2-dihydroxypropyl substituent has 1S,2R configuration.
(6R)-L-erythro-6,7-dihydrobiopterin
A 6,7-dihydrobiopterin that has R configuration at position 6 and in which the 1,2-dihydroxypropyl substituent has 1R,2S configuration.
Acetyl-L-carnitine (hydrochloride)
Acetyl-L-carnitine (O-Acetyl-L-carnitine) hydrochloride is a blood-brain permeable acetyl ester of the amino acid L-carnitine found in the body. Acetyl-L-carnitine hydrochloride is often used as a dietary supplement, and exibits anti-stress-related psychiatric disorders[1].
